Clinical Trial Update: Phase II Clinical Study to Evaluate the Efficacy and Safety of XKH001 Injection [Phase 2]

View source ↗

Summary

A Phase II clinical trial is evaluating the efficacy and safety of XKH001 Injection for chronic obstructive pulmonary disease, with the study status listed as n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• XKH001 Injection

Snippet

Sponsor: Zhejiang Kanova Biopharmaceutical Co., LTD | Conditions: COPD | Phase 2 | Status: NOT_YET_RECRUITING